Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.9 USD | +6.39% | +31.29% | +18.11% |
Apr. 16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
Apr. 11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.11% | 665M | |
-1.58% | 102B | |
+2.58% | 96.09B | |
+2.13% | 22.28B | |
-16.15% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-14.05% | 16.09B | |
+6.22% | 13.83B | |
+33.57% | 11.97B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- JPMorgan Adjusts Price Target on AnaptysBio to $32 From $24, Maintains Underweight Rating